Allergan plc (NYSE: AGN) is a large market cap stock with a market cap of 94125.11. It is in the Drugs – Generic industry and sector Healthcare, with a current P/E of *TBA, a forward P/E of 13.89 and EPS of -6.14. At a stock price of 237.93 (0.69%) it has a dividend yield of *TBA.
EPS growth for the last five years have been -50.40%, more recently this last year it has grown by 23.00%. The next year growth is going to be about 22.38% and more long-term 13.49% after five years. EPS growth quarter over quarter is 78.20%. Sales growth for the past five years have been 33.40% and sales growth quarter over quarter is -77.20%.
For performance, Allergan plc the past week has seen a gain of -6.01%. For the last month performance for Allergan plc is -6.90%. While the last quarter is 0.84% and half year, -17.99%. Finally for the year, performance is -23.74%.
The 52-week high for Allergan plc, is at -26.26%, and for the 52-week low it comes to a value of 21.70%. The 20-day simple moving average is -2.44% and -10.25% for the 200-day simple moving average.
Volatility for the week is at 2.81%, and for the month it is 1.92%. Allergan plc, has a target price of 299.06.
In terms of debt, long term debt/equity is 0.52, and for total debt/equity Allergan plc has 0.56. The gross margin is 78.70%, while operating margin is -17.50%, the profit margin is 28.20%. The current ratio is 1 and the quick ratio is 0.9.
Insider ownership is at 0.10%, with instituitional ownership at 87.60%. Allergan plc has a payout ratio of 0.00%. With the total shares outstanding coming to 395.6. The shares float is 395.29, with the float short at 1.49%, with short ratio coming to 1.84.
In terms of returns, the return on assets see Allergan plc, get 3.20%, with its returns on investment at -1.30%. Return on equity is 6.00%. So will the investors see the target price of 299.06, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.